Welcome to our dedicated page for Marsh & Mclennan SEC filings (Ticker: MMC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Marsh & McLennan Companies, Inc. filings document a global professional services firm with businesses in risk, reinsurance and capital, people and investments, and management consulting. The record includes 8-K reports for quarterly and annual operating results, officer appointments and compensation actions, director changes, bylaw amendments, and other material events.
Proxy materials describe annual meeting matters, board governance, executive compensation and stockholder voting. Capital-market filings cover common stock registered on the New York Stock Exchange and NYSE Texas, shelf registration use, underwriting agreements, senior notes, indenture supplements and related exhibits for the company's advisory and consulting businesses.
Marsh & McLennan Companies President and CEO John Q. Doyle reported an option exercise and related share sale. He exercised options to acquire 16,656 shares of Common Stock at $73.195 per share, then sold 16,656 shares at $161.71 per share in an open‑market transaction.
The filing notes that the sale was effected under a pre‑arranged Rule 10b5‑1 trading plan, meaning it was scheduled in advance. After these transactions, Doyle continues to hold over 100,000 shares of Marsh & McLennan stock directly.
Marsh & McLennan Companies director Morton O. Schapiro received an annual equity grant of 1,349.82 restricted stock units. The award, made under the Marsh & McLennan Companies Directors Stock Compensation Plan, is valued at a reference price of $159.28 per unit and converts into common stock on a 1-for-1 basis.
Following this grant, Schapiro directly holds 90,445.40 shares of common stock, including the underlying shares from these units. This is a compensation-related award rather than an open-market purchase or sale.
Marsh & McLennan Companies director Anthony Anderson received an annual equity grant of 1,349.82 restricted stock units. The award was made under the Marsh & McLennan Companies Directors Stock Compensation Plan and is classified as a grant or award acquisition, not an open-market purchase.
The restricted stock units convert into Marsh & McLennan common stock on a 1-for-1 basis, aligning the director’s compensation with future share performance. Following this grant, Anderson holds a total of 17,082.15 units directly, reinforcing his equity stake in the company.
Marsh & McLennan Companies director Deborah C. Hopkins received an annual equity grant under the company’s Directors Stock Compensation Plan. She was awarded 1,349.82 restricted stock units that convert into common stock on a 1-for-1 basis, reflecting a reference price of $159.28 per share. Following this grant, she directly holds 21,414.56 shares-equivalent of common stock. This is a compensation-related award, not an open-market purchase or sale.
Marsh & McLennan Companies director Tamara Ingram received an annual stock award in the form of 1,349.82 restricted stock units under the company’s Directors Stock Compensation Plan. These units convert into common stock on a 1-for-1 basis.
After this grant, Ingram directly holds 9,086.35 shares-related units, reflecting routine, compensation-based equity rather than an open-market purchase or sale.
Marsh & McLennan Companies director Lloyd M. Yates received an annual stock award of restricted stock units. On June 1, 2026, he was granted 1,349.82 restricted stock units under the Directors Stock Compensation Plan. These units convert into common stock on a 1-for-1 basis, bringing his directly held equity-related position reported in this filing to 12,390.99 shares on a converted basis. This is a compensation-related equity grant rather than an open-market share purchase or sale.
Marsh & McLennan Companies director Jane H. Lute received an equity award through the company’s director stock plan. She was granted 1,349.82 restricted stock units on June 1, 2026, which convert into common stock on a 1-for-1 basis. Following this grant, she holds 8,911.69 derivative shares linked to common stock. The award is classified as a grant or other acquisition, reflecting routine director compensation rather than an open‑market trade.
Marsh & McLennan Companies director Jan Siegmund received an annual stock award of 1,349.82 restricted stock units on Marsh & McLennan common stock. The units were valued at $159.28 per underlying share and convert into common stock on a 1-for-1 basis.
Following this grant, Siegmund directly holds 2,298.24 restricted stock units linked to Marsh & McLennan common stock. This is a compensation-related award rather than an open-market purchase or sale.
MILLS STEVEN A reported acquisition or exercise transactions in this Form 4 filing.
MARSH & MCLENNAN COMPANIES, INC. director Steven A. Mills reported an annual stock award, not an open‑market trade. He received a grant of 1,349 shares of common stock at $159.28 per share under the Marsh & McLennan Companies Directors Stock Compensation Plan. After this compensation grant, he holds 5,757.75 shares directly and 47,553 shares indirectly through a trust.
HANWAY H EDWARD reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies director H. Edward Hanway received an annual stock award of 1,349 shares of Common Stock. The award was granted on June 1, 2026 under the Marsh & McLennan Companies Directors Stock Compensation Plan at a reference price of $159.28 per share.
After this grant, Hanway directly holds a total of 36,867.7 shares of Marsh & McLennan common stock. This is a compensation-related equity award, not an open‑market purchase or sale.